Enzo Biochem, Inc. (ENZ)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 53.27M |
| Enterprise Value | 214.76k |
| Trailing P/E | 100.67 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.58 |
| Price/Book (mrq) | 0.75 |
| Enterprise Value/Revenue | 0.01 |
| Enterprise Value/EBITDA | -0.01 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.71 |
| 52-Week Change 3 | -59.53% |
| S&P500 52-Week Change 3 | 21.33% |
| 52 Week High 3 | 2.7400 |
| 52 Week Low 3 | 1.0100 |
| 50-Day Moving Average 3 | 1.2272 |
| 200-Day Moving Average 3 | 1.3464 |
Share Statistics
| Avg Vol (3 month) 3 | 111.74k |
| Avg Vol (10 day) 3 | 109.6k |
| Shares Outstanding 5 | 51.23M |
| Implied Shares Outstanding 6 | 51.23M |
| Float 8 | 39.35M |
| % Held by Insiders 1 | 24.19% |
| % Held by Institutions 1 | 39.43% |
| Shares Short (Apr 15, 2024) 4 | 729.23k |
| Short Ratio (Apr 15, 2024) 4 | 7.84 |
| Short % of Float (Apr 15, 2024) 4 | 1.88% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 1.42% |
| Shares Short (prior month Mar 15, 2024) 4 | 733.14k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 105:100 |
| Last Split Date 3 | Oct 21, 2004 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Jul 31, 2023 |
| Most Recent Quarter (mrq) | Jan 31, 2024 |
Profitability
| Profit Margin | 99.28% |
| Operating Margin (ttm) | -25.55% |
Management Effectiveness
| Return on Assets (ttm) | -16.53% |
| Return on Equity (ttm) | -45.01% |
Income Statement
| Revenue (ttm) | 32.8M |
| Revenue Per Share (ttm) | 0.66 |
| Quarterly Revenue Growth (yoy) | 13.80% |
| Gross Profit (ttm) | N/A |
| EBITDA | -21.43M |
| Net Income Avi to Common (ttm) | -23.32M |
| Diluted EPS (ttm) | -0.4700 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 60.24M |
| Total Cash Per Share (mrq) | 1.18 |
| Total Debt (mrq) | 7.18M |
| Total Debt/Equity (mrq) | 10.15% |
| Current Ratio (mrq) | 3.20 |
| Book Value Per Share (mrq) | 1.40 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -44.4M |
| Levered Free Cash Flow (ttm) | -4.44M |
© 2024 Yahoo. All rights reserved.